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Background/Aims: The incidence rate of nontuberculous mycobacterial pulmo-
nary disease (NTM-PD) is increasing worldwide. However, data regarding the 
age- and sex-specific epidemiology of NTM-PD are limited. This study aimed to 
investigate the long-term epidemiologic trends of NTM-PD within the recent 11-
year period in a tertiary referral hospital in Korea.
Methods: We retrospectively reviewed the medical records of the patients diag-
nosed with NTM-PD between January 2006 and December 2016 at Severance 
Hospital, South Korea.
Results: There were 1,017 incident cases with NTM-PD during the study period. 
The mean age was 62.7 years, and 41.2% were men. Women were younger than 
men (59.9 years vs. 66.7 years, p < 0.001) and a higher proportion of women had 
bronchiectasis (88.6% vs. 77.1%, p < 0.001). The incidence rates of NTM-PD annu-
ally increased by 14% (95% confidence interval, 10% to 19%) from 1.2 in 2006 to 
4.8 in 2016 (per 100,000 patients-year). The peak incidence rate was in the 50s for 
women and in the 70s for men, except for those aged ≥ 80 years. Mycobacterium avi-
um complex was the most common causative species of NTM-PD (63.6%).
Conclusions: The incidence rate of NTM-PD in a tertiary referral hospital in 
South Korea continued to increase from 2006 to 2016. Furthermore, there were 
age- and sex-related differences in the clinical characteristics, which might con-
tribute to understanding the nature of the disease and inherited and acquired 
host factors.
Keywords: Nontuberculous mycobacteria; Nontuberculous mycobacterium infec-
tion; Lung diseases
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INTRODUCTION
Nontuberculous mycobacteria (NTM) represent a di-
verse group of mycobacterial species; this complex dif-
fers from the Mycobacterium tuberculosis complex and 
Mycobacterium leprae. NTM are ubiquitous environmen-
tal bacteria and are mainly present in the natural and 
drinking water systems, pools and hot tubs, biofilms, 
and soil [1]. They can affect various tissues and body 
fluids, causing pulmonary and extrapulmonary diseas-
es [2,3]. Although NTM are considered opportunistic 
pathogens, the incidence and prevalence rate of NTM 
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pulmonary disease (NTM-PD) are increasing world-
wide, not only in the immune-compromised, but also 
in the immune-competent patients [2-4]. Furthermore, 
there are significant geographic differences in the dis-
tribution of NTM primarily due to the environmental 
nature of these microorganisms [5]. 
In South Korea, a country with an intermediate tuber-
culosis (TB) burden [6], NTM are also emergent patho-
gens, and NTM-PD is rapidly becoming a significant 
public health concern. Several studies have reported an 
increase in both the NTM recovery rate in clinical speci-
mens and the incidence and prevalence rate of NTM-PD 
in South Korea [7-13]. However, comprehensive analyses 
of the clinical and epidemiologic data for NTM-PD are 
relatively scarce compared to that of TB because NTM-
PD is not a reportable disease in most countries, and 
complicated criteria and extensive follow-up are re-
quired for diagnosis.
We had previously reported the change in the NTM 
epidemiology in a tertiary referral hospital in South Ko-
rea between 2006 and 2010 [7]. In this study, we aimed 
to investigate the long-term epidemiologic trends of 
NTM-PD within the recent 11-year period in a tertiary 
referral hospital in South Korea. Moreover, we intend 
to perform comprehensive analyses of NTM-PD and its 
association with age and sex.
METHODS
Study design and data collection
We retrospectively analyzed the mycobacterial culture 
records at Severance Hospital, a tertiary referral hos-
pital in Seoul, South Korea, from January 2006 to De-
cember 2016. The culture results from the pulmonary 
specimens were included, and those from the extrapul-
monary samples were excluded. NTM-PD was defined 
according to the American Thoracic Society/Infectious 
Disease Society of America (ATS/IDSA) criteria [2]. An 
incident case of NTM-PD in a specific year was defined 
as the year of the first recovery date of NTM in a respi-
ratory specimen. The data on age, sex, body mass index, 
comorbidities, and spirometry results within 6 months 
from the first recovery date of each patient were retro-
spectively obtained from the medical records.
Microbiological examination
Respiratory specimens, such as sputum and bronchial 
washing fluid, were stained according to the ATS/IDSA 
guidelines [2], decontaminated with 4% NaOH, homoge-
nized, and concentrated via centrifugation. Liquid medi-
um (mycobacteria growth-indicator tube) has been used 
in Severance Hospital since 2008. The detailed informa-
tion regarding specimen processing has been published 
previously [7]. We identified the NTM species with poly-
merase chain reaction-restriction fragment length poly-
morphism analysis based on the rpoB gene [14]. 
Causative species of NTM-PD
We defined the causative species of NTM-PD as the 
NTM species identified two or more times in the spu-
tum or once in the bronchial wash or lavage. If there are 
two or more causative species of NTM-PD, we defined 
the disease as multi-species NTM-PD.
Radiologic evaluation
The radiologic patterns of NTM-PD were classified into 
three groups according to the chest radiography and 
computed tomography (CT) findings [2]. The fibrocav-
itary (FC) form was defined as the presence of cavitary 
opacities in the upper lobes, either with or without con-
solidation and pleural thickening. The nodular bronchi-
ectatic (NB) form was defined as bilateral bronchiectasis 
with multiple nodules and tree-in-bud opacities. The 
unspecified form was defined as the absence of evident 
characteristics of either form.
Incidence rate of NTM-PD
The incidence rate of NTM-PD was calculated as the 
number of patients with NTM-PD divided by the annual 
total number of patients who visited Severance Hospi-
tal. We also investigated the age group- and sex-specific 
incidence rates, detection rates of each causative species, 
and the female-to-male rate ratio of NTM-PD.
Statistical analysis
The categorical variables were analyzed with Pearson’s 
chi-squared test or Fisher’s exact test, while the con-
tinuous variables were analyzed with Student’s t test. A 
Cochran-Armitage trend test was used for the analysis 
of the changing trends, and Poisson regression models 
with allowance for overdispersion were fit to the collect-
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ed data for the analysis of the incidence rate change. The 
fitted model was used to calculate the annual percent 
change in the incidence rate. All statistical analyses were 
performed using R v3.6.0 (R Foundation for Statistical 
Computing, Vienna, Austria), and a two-tailed p < 0.05 
was considered statistically significant.
Ethics statement
The study protocol was reviewed and approved by the 
Institutional Review Board of Severance Hospital (No. 
4-2018-0350), and the need for obtaining informed con-
sent was waived by the committee due to the retrospec-
tive nature.
RESULTS
Respiratory specimens and patients
We reviewed 306,008 respiratory samples from 64,627 
patients during the study period. NTM isolates were re-
covered in 17,485 (5.7%) specimens, and the recovery rate 
(95% confidence interval [CI]) increased from 1.9% (95% 
CI, 1.7% to 2.2%) in 2006 to 7.4% (95% CI, 7.2% to 7.7%) 
in 2016 (p for trend < 0.001). NTM were newly observed 
in 3,843 patients during the study period, of whom 1,017 
(26.5%) patients satisfied the criteria for NTM-PD. The 
annual number of incident cases of NTM-PD and pa-
tients who visited this institution are presented in Sup-
plementary Table 1.
Clinical characteristics and incidence rate of NTM-
PD according to the sex and age
The baseline characteristics of the patients with NTM-
PD are shown in Table 1. Women were younger than 
men. The rates of bronchiectasis and NB form were 
higher among women than that among men. The pro-
portion of patients with a history of pulmonary TB or 
chronic obstructive pulmonary disease (COPD) was 
higher among men than among women.
Fig. 1 shows the age distribution of the patients with 
NTM-PD. Most male patients were in their 60s and 
70s, whereas most female patients were in their 50s and 
early 60s. The incidence rate of patients with NTM-
PD showed a similar distribution according to the age 
group (Supplementary Table 2). The peak incidence rate 
of NTM-PD was in the 50s for women and in the 70s 
for men, except for those aged ≥ 80 years. The overall 
incidence rate increased as age increased for both sex-
es, with male patients showing an 83% (95% CI, 57% to 
117%) increase in the overall incidence rate, and female 
patients showing a 47% (95% CI, 20% to 86%) increase. 
The female-to-male incidence rate ratio was lower than 
1 for patients aged ≥ 70 years (Supplementary Table 2).
Fig. 2A shows the sex-specific incidence rate for pa-
tients with NTM isolated from the respiratory spec-
imens and patients with NTM-PD in each year from 
2006 to 2016. The incidence rate of the isolated NTM 
was 4.6 (95% CI, 3.7 to 5.6) in 2006 and increased to 19.6 
(95% CI, 18.0 to 21.3) in 2016 (p for trend < 0.001), while 
the incidence rate of NTM-PD was 1.2 (95% CI, 0.8 to 1.8) 
in 2006 and increased to 4.8 (95% CI, 4.1 to 5.7) in 2016 
(p for trend < 0.001). Poisson regression analysis showed 
that the incidence rate of NTM-PD increased annual-
ly by 14% (95% CI, 10% to 19%) in the total population. 
Fig. 2B shows the age group-specific incidence rate of 
NTM-PD. The increasing trend of NTM-PD was more 
prominent in the older population (annual percentage 
change—in the 40s, 6% [95% CI, –1% to 14%]; in the 50s, 
9% [95% CI, 4% to 15%]; in the 60s, 12% [95% CI, 7% to 
18%]; in the 70s, 17% [95% CI, 10% to 25%]; and in the 
80s: 17% [95% CI, 6% to 30%]).
Causative species of NTM-PD
The most commonly isolated NTM species from the 
patients with NTM-PD were M. avium complex (MAC, 
M. avium and M. intracellulare), followed by M. abscessus 
complex (MABC, M. abscessus and M. massiliense) (Table 
2). Multi-species NTM-PD was identified in 20.2% of 
the patients, and the rate of multi-species NTM-PD was 
higher among women than among men. M. kansasii in-
fection was more common among the male patients and 
in those with the FC form disease.
Fig. 3 shows the causative species of NTM-PD during 
the study period. Notably, the most predominant caus-
ative species was MAC, and the proportion showed no sig-
nificant variation for 11 years (p for trend = 0.072). MABC 
tended to decrease over time (p for trend = 0.035). These 
findings suggest that the increase in the incidence rate of 
NTM-PD is mainly because of the increase in MAC.
Radiologic forms of NTM-PD
The predominant radiologic findings of NTM-PD were 
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NB form, accounting for an average of 78% of the cas-
es; this further increased over time (p for trend < 0.001) 
(Fig. 4). This was followed by the FC form (14%), but the 
proportion of patients with the FC form decreased (p for 
trend < 0.001). The average proportion of patients with 
the NB form was higher among women than among 
men (85% vs. 69%), but similar patterns of increased 
proportion of the NB form and decreased proportion 
of the FC form were found among the male and female 
subgroups (p for trend < 0.001 for both) (Supplementary 
Fig. 1).
DISCUSSION
This study found that the incidence rate of NTM-PD 
continued to increase between 2006 and 2016 in a tertia-
ry hospital in South Korea. Moreover, there were some 
differences in the clinical characteristics of the patients 
with NTM-PD according to age, sex, and radiologic 
forms of the disease. 
An increased rate of isolated NTM and NTM-PD has 
been reported worldwide. In Korea, the incidence rate 
of NTM continues to increase despite no significant 
Table 1. Characteristics of the patients with nontuberculous mycobacterial pulmonary disease
Characteristic Total (n = 1,017) Male (n = 419) Female (n = 598) p value
Age, yr 62.7 ± 11.7 66.7 ± 10.8 59.9 ± 11.6 < 0.001
Body mass index, kg/m2 20.5 ± 4.1 20.6 ± 4.8 20.4 ± 3.4 0.448
Smoking status < 0.001
Never smoker 731 (73.0) 164 (39.3) 567 (96.9)
Ever smoker 271 (27.0) 253 (60.7) 18 (3.1)
Pack-year 28.6 ± 21.6 29.1 ± 22.1 20.4 ± 11.4 0.024
Previous tuberculosis 491 (48.3) 238 (56.8) 253 (42.3)  < 0.001
Comorbidity
Bronchiectasis 853 (83.9) 323 (77.1) 530 (88.6) < 0.001
COPD 137 (13.5) 102 (24.3) 35 (5.9) < 0.001
Asthma 74 (7.3) 28 (6.7) 46 (7.7) 0.626
Lung cancer 41 (4.0) 19 (4.5) 22 (3.7) 0.602
Other pulmonary diseasesa 21 (2.1) 7 (1.7) 14 (2.3) 0.606
Malignancy, other than lung 238 (23.4) 116 (27.7) 122 (20.4) 0.009
Diabetes mellitus 137 (13.5) 75 (17.9) 62 (10.4) 0.001
Transplantation 16 (1.6) 12 (2.9) 4 (0.7) 0.012
Immune-compromised 5 (0.5) 2 (0.5) 3 (0.5) > 0.999
No comorbidityb 13 (1.3) 6 (1.4) 7 (1.2) 0.935
Radiologic pattern  < 0.001
Fibrocavitary form 103 (10.1) 65 (15.5) 38 (6.4)
Nodular bronchiectatic form 831 (81.7) 309 (73.7) 522 (87.3)
Unspecified 83 (8.2) 45 (10.7) 38 (6.4)
Lung function 344 173 171
FVC, % predicted 80.9 ± 21.8 74.6 ± 21.6 87.3 ± 20.2 < 0.001
FEV1, % predicted 85.6 ± 49.9 81.6 ± 66.1 89.7 ± 23.8 0.129
FEV1/FVC 72.5 ± 13.2 70.5 ± 15.4 74.5 ± 10.2 0.005
Values are presented as mean ± SD or number (%).
COPD, chronic obstructive pulmonary disease; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second.
aPulmonary disease other than tuberculosis, COPD, asthma, bronchiectasis, and lung cancer. 
bPatients without any comorbidities listed in this table.
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change in the incidence rate of TB (88/100,000 in 2006, 
and 77/100,000 in 2016) [6,15]. One of the most tradition-
al explanations for this increase is improved detection 
rates with new laboratory techniques, frequent CT scans 
during medical check-ups, and increasing awareness of 
NTM by the medical staff. However, this detection bias 
may also be partly due to other reasons. In our institu-
tion, the increase in the recovery rate was more prom-
inent for NTM than for M. tuberculosis when we used a 
combination of liquid and solid media for mycobacteri-
al culture, as has previously been reported [16]. However, 
when we re-analyzed the mycobacterial recovery rate for 
the solid culture medium, an increasing trend for NTM 
isolates and patients with NTM-PD was also evident [7]. 
Therefore, the increase in the detection of NTM isolates 
and patients with NTM-PD in this study could not be 
fully explained by the introduction of the liquid culture 
Figure 1. Age distribution of the patients with nontubercu-
lous mycobacterial pulmonary disease.



















































Figure 2. Incidence rate of the isolated nontuberculous mycobacteria (NTM) and NTM pulmonary disease (NTM-PD; per 
100,000 person-year). (A) Incidence rate of the patients with isolated NTM and with NTM-PD according to sex. (B) Incidence 
rate of the patients with NTM-PD according to the age group and its annual increase percent. The p value obtained by Poisson 








p for trend (total) < 0.001
p for trend (total) < 0.001
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Table 2. Causative species of NTM-PD according to age and radiologic type
 
Total







 (n = 103)
Nodular 
bronchiectatic
 (n = 831)
p value
MAC 647 (63.6) 281 (67.1) 366 (61.2) 0.065 65 (63.1) 531 (63.9) 0.961
MABC 110 (10.8) 38 (9.1) 72 (12.0) 0.162 10 (9.7) 85 (10.2) > 0.999
M. fortuitum 21 (2.1) 12 (2.9) 9 (1.5) 0.202 4 (3.9) 15 (1.8) 0.148
M. kansasii 21 (2.1) 15 (3.6) 6 (1.0) 0.009 6 (5.8) 10 (1.2) 0.005
Others 13 (1.3) 11 (2.6) 2 (0.3) 0.004 3 (2.9) 9 (1.1) 0.137
Multi-species 205 (20.2) 62 (14.8) 143 (23.9)  < 0.001 15 (14.6) 181 (21.8) 0.117
Values are presented as number (%) .
NTM-PD, nontuberculous mycobacterial pulmonary disease; MAC, Mycobacterium avium complex; MABC, M. abscessus complex.
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methods.
We hypothesized that the increase in the incidence 
rate of NTM-PD was a multifactorial event that includes 
aging of the general population, an increasing number 
of patients with comorbidities, and environmental fac-
tors. Previous studies have reported that age is related to 
the increase in the incidence rate of NTM-PD in both 
young and old populations [17,18]. Al-Houqani et al. [19] 
reported that age is considered to play the major role in 
the increase of NTM-PD incidence; however, they also 
stated that age accounted for less than 25% of the total 
increase. In the current study, the incidence rate and its 
increase were more prominent in the old population 
than in the total population (Fig. 2B). We classified the 
patients according to age in decades and found an in-
crease in the annual percent change in the incidence 
rate according to age. Prevots et al. [20] showed similar 
results; they found a higher increase in the annual prev-
alence in individuals aged ≥ 60 years than in those aged 
< 60 years. Adjemian et al. [21] also calculated the adjust-
ed odds ratio of the NTM-PD incidence in different age 
groups compared to that in patients aged < 18 years, and 
reported that it is increased according to age: 7.4 (95% 
CI, 2.9 to 19.3) in patients aged 18 to 49 years; 31.2 (95% CI, 
12.2 to 79.7), patients aged 50 to 64 years; and 106.4 (95% 
CI, 42.0 to 270.0), patients aged ≥ 65 years. 
Chronic lung diseases, such as COPD, bronchiectasis, 
cystic fibrosis, and pneumoconiosis are important pre-
disposing factors for the development of NTM-PD [4]. 
The underlying structural lung disease and airway dys-
function may intuitively reduce the clearance of the 
inhaled environmental microorganisms. The preva-
lence of bronchiectasis markedly increases with age, 
and NTM infection easily occurs as a comorbidity with 
bronchiectasis [22]. In the current study, bronchiectasis 
(83.9%) was the most frequently associated chronic lung 
disease, followed by previous pulmonary TB (48.3%) and 
COPD (13.5%). Furthermore, the proportion of the pa-
tients with NB form also increased significantly during 
the study period (Fig. 4 and Supplementary Fig. 1). It is 
unclear whether NTM-PD is a cause or the consequence 
of bronchiectasis, but both notions are supported by 
accumulated evidence [23]. A history of pulmonary TB 
and other pulmonary infections can be a risk factor 
for bronchiectasis and structural lung disease. The in-
creased global burden of COPD and use of corticoste-
roid inhalation could partly explain the increasing trend 
of NTM-PD incidence [24,25]. 
We found an increased number of NTM-PD patients 
and a stable proportion of patients with MAC-PD, which 
implies that MAC infection is the main reason for the 
increasing trends in this study. In South Korea, MAC is 
the most common organism causing NTM-PD [1]. Ko 
et al. [12] suggested that the proportion of MAC infec-
tion, especially of M. avium, has increased over 15 years 
in Korea . An American study also revealed an increasing 
Figure 3. Proportion of the causative nontuberculous my-
cobacteria (NTM) species in the patients with NTM pulmo-
nary disease (NTM-PD). MAC, Mycobacterium avium com-
plex; MABC, M. abscessus complex.
Figure 4. Radiologic types of nontuberculous mycobacterial 
pulmonary disease.
2006 2007
MAC MABC OthersM. fortuitum M. kansasii
2008 2009 2010 2011
Year





















Nodular bronchiectatic Fibrocavitary Others
2008 2009 2010 2011
Year






















       
1430 www.kjim.org https://doi.org/10.3904/kjim.2019.395
The Korean Journal of Internal Medicine Vol. 35, No. 6, November 2020
trend of MAC infection with relatively stable numbers of 
all other NTM species over the last 8 years [21]. 
A few studies have indicated the sex-related differenc-
es in the clinical characteristics of NTM-PD. In a French 
retrospective study, men were younger than women (48.1 
years vs. 55.0 years, p = 0.04), and they showed more con-
siderable improvement at 1 year (odds ratio, 2.34; 95% 
CI, 1.26 to 8.16) [26]. However, the study included a small 
number of patients (n = 119), and the 1-year mortality rate 
was higher among men. In a Japanese cross-sectional 
study that included 11,034 patients with NTM-PD identi-
fied from a national database, the incidence rate of NTM-
PD was higher among women in all age groups except for 
those aged ≥ 80 years, which was similar to the results of 
our study [27]. Holt et al. [28] reported more severe dis-
ease in women, evidenced by more cavitation of the lung, 
lower body mass index, and more extensive treatment 
history, and a trend towards more marked ventilatory 
impairment. However, we could not evaluate the severity 
or treatment history of NTM-PD using our data.
In the current study, women were younger than men, 
and the peak incidence rate of NTM-PD was in the 50s 
for women, while that in men was in the 70s. Multi-spe-
cies NTM-PD was more common in women. Comor-
bidities were also different; bronchiectasis was more 
common in women, whereas a higher proportion of 
men had a history of TB and COPD. This indicates that 
the reason for increasing NTM-PD incidence rate may 
differ according to the sex. Nevertheless, the data sup-
porting the sex-related difference hypothesis were lim-
ited and equivocal; therefore, prospective studies with a 
larger cohort are needed.
There are a few limitations of this study. First, the 
study had a retrospective design. We can only assume 
the correlation between the disease and clinical charac-
teristics. Second, we analyzed the data from a single cen-
ter. Although a relatively high numbers of samples and 
patients were included in the investigation, the clini-
codemographic characteristics of the patients visiting 
our hospital might have affected the result. Third, our 
institution is a referral hospital frequented by patients 
with comorbidities. Therefore, the data may not repre-
sent the general epidemiology in South Korea due to 
the referral bias. Fourth, environmental factors for each 
patient were not considered as part of this retrospective 
study.
In conclusion, the increased incidence rate of NTM-
PD continued from 2006 to 2016 at a tertiary referral 
hospital in South Korea, possibly owing to the aging 
of the general population with comorbidities. Further-
more, there might be some age- and sex-related differ-
ences in the clinical characteristics. As the incidence 
rate of NTM-PD is projected to continue to increase, a 
prospective evaluation to understand the nature of the 
disease and the inherited and acquired host factors is 
warranted.
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Pulmonology department Total number
Inpatient Percentage Outpatient Percentage Inpatient Outpatient
2006 25 2,166 2.81 35,612 1.85 77,091 1,928,072
2007 26 2,123 2.68 36,183 1.80 79,249 2,013,407
2008 42 2,108 2.36 33,293 1.57 89,358 2,122,755
2009 66 2,169 2.32 34,036 1.51 93,295 2,255,658
2010 85 1,991 2.12 33,630 1.41 93,870 2,386,545
2011 90 2,184 2.23 36,840 1.50 98,045 2,455,259
2012 120 2,071 2.05 39,030 1.55 100,995 2,523,757
2013 123 2,199 2.20 40,358 1.60 99,936 2,520,929
2014 145 2,227 2.18 41,104 1.60 102,323 2,573,775
2015 155 2,617 2.42 46,699 1.76 108,340 2,650,634
2016 140 2,484 2.20 50,844 1.82 112,837 2,794,034
NTM-PD, nontuberculous mycobacterial pulmonary disease.
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Supplementary Table 2. Age and sex profiles of the incident cases of NTM-PD and incidence rate (per 100,000 person-year) 
during the study period
Age group, 
 yr






No. (%) Incidence rate (95% CI) No. (%) Incidence rate (95% CI)
30–39 5 (1.2) 0.5 (0.2–1.1) 19 (3.2) 1.1 (0.7–1.8) 2.4 1,081,209 1,704,841
40–49 13 (3.1) 0.9 (0.5–1.6) 74 (12.4) 3.5 (2.8–4.5) 3.9 1,445,775 2,091,878
50–59 69 (16.5) 3.2 (2.5–4.1) 207 (34.6) 7.2 (6.3–8.3) 2.2 2,129,300 2,869,038
60–69 143 (34.1) 6.1 (5.2–7.2) 158 (26.4) 6.2 (5.3–7.3) 1.0 2,338,416 2,531,907
70–79 150 (35.8) 9.1 (7.7–10.7) 108 (18.1) 6.8 (5.6–8.2) 0.7 1,654,679 1,596,645
≥ 80 36 (8.6) 9.5 (6.7–13.2) 28 (4.7) 7.5 (5.0–10.9) 0.8 380,805 375,772
Total 419 (100) 3.3 (3.0–3.6) 598 (100) 4.0 (3.7–4.4) 1.2 12,798,235 14,829,610
NTM-PD, nontuberculous mycobacterial pulmonary disease; CI, confidence interval.
aRatio of female to male incidence rate.
 
       
www.kjim.org
The Korean Journal of Internal Medicine Vol. 35, No. 6, November 2020
https://doi.org/10.3904/kjim.2019.395
2006 2007
Nodular bronchiectatic Fibrocavitary Others
2008 2009 2010 2011
Year























Nodular bronchiectatic Fibrocavitary Others
2008 2009 2010 2011
Year























Supplementary Figure 1. Radiologic types of nontuberculous mycobacterial pulmonary disease in (A) male and (B) female 
patients.
